Technical Analysis for AYTU - Aytu BioScience, Inc.

Grade Last Price % Change Price Change
grade F 1.41 -0.70% -0.01
AYTU closed down 0.7 percent on Thursday, September 19, 2019, on 1.23 times normal volume. It ran into resistance at its 50 day moving average.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical AYTU trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
20 DMA Support Bullish 0.00%
Doji - Bullish? Reversal 0.00%
Upper Bollinger Band Touch Strength 0.00%
200 DMA Resistance Bearish -0.70%
50 DMA Resistance Bearish -0.70%
Death Cross Bearish -0.70%
Volume Surge Other -0.70%
Upper Bollinger Band Walk Strength -0.70%
Outside Day Range Expansion -0.70%

Older signals for AYTU ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Aytu BioScience, Inc. is a commercial-stage healthcare company focused on acquiring, developing and commercializing products in the field of urology. The Company focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility. The Company markets ProstaScint (capromab pendetide), a radio imaging agent indicated to detect the prostate specific membrane antigen (PSMA) in the assessment and staging of prostate cancer. The Company's pipeline includes MiOXSYS, an in vitro diagnostic device. MiOXSYS system is a point-of-care semen analysis system, used for diagnosis and management of male infertility. The Company holds the United States rights to Natesto (testosterone), a formulation of testosterone delivered through a nasal gel. Natesto is used for the treatment of hypogonadism (low testosterone) in men. The Company, through its wholly-owned subsidiary Nuelle, Inc., is focused on women’s sexual wellbeing and intimacy.
Healthcare Organ Systems Prostate Cancer Alcohols Hormones Ketones Company's Pipeline Urinary Tract Infections Androstanes Male Infertility Testosterone
Is AYTU a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.0
52 Week Low 0.68
Average Volume 134,564
200-Day Moving Average 1.4981
50-Day Moving Average 1.477
20-Day Moving Average 1.3799
10-Day Moving Average 1.4013
Average True Range 0.1069
ADX 13.11
+DI 19.4556
-DI 14.9345
Chandelier Exit (Long, 3 ATRs ) 1.2193
Chandelier Exit (Short, 3 ATRs ) 1.5507
Upper Bollinger Band 1.4622
Lower Bollinger Band 1.2976
Percent B (%b) 0.68
BandWidth 11.928401
MACD Line -0.0082
MACD Signal Line -0.0245
MACD Histogram 0.0163
Fundamentals Value
Market Cap 5.67 Million
Num Shares 4.02 Million
EPS -48.30
Price-to-Earnings (P/E) Ratio -0.03
Price-to-Sales 4.58
Price-to-Book 0.76
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.60
Resistance 3 (R3) 1.61 1.54 1.57
Resistance 2 (R2) 1.54 1.49 1.54 1.56
Resistance 1 (R1) 1.48 1.46 1.44 1.47 1.55
Pivot Point 1.41 1.41 1.40 1.41 1.41
Support 1 (S1) 1.35 1.36 1.32 1.35 1.27
Support 2 (S2) 1.28 1.33 1.28 1.26
Support 3 (S3) 1.22 1.28 1.25
Support 4 (S4) 1.22